Japan Sake and Shochu Makers Association Announces 2024 Sake Export Data: Record-High Exports to 80 Countries, Up 6% YoY
More people around the world are enjoying Japanese sake (Photo: Business Wire)
The Japan Sake and Shochu Makers Association (JSS) has released 2024 sake export data. The total export value reached JPY 43.5 billion, a +6% increase from the previous year, with 3.45 million cases (9L equivalent) shipped to a record 80 countries. Since 2020, export value has grown 1.8 times, the average unit price increased 1.3 times, and the number of export destinations expanded by 19. Premium sake markets have seen significant growth in the past five years.
Regionally, Asia accounted for 61% of total export value but saw a slight decline YoY. However, South Korea recorded a notable 29% growth, while Thailand and Malaysia also performed well. North America saw a 27% increase, driven by fine-dining adoption. Western Europe grew 18% YoY, expanding 2.5 times over five years due to wine industry collaborations. The UK and France, in particular, expanded approximately threefold and 2.6 times, respectively.
JSS's 2024 Key Initiatives and Future Outlook
To enhance global awareness of sake, JSS has strengthened partnerships with the Association de la Sommellerie Internationale (ASI) and the Union de la Sommellerie Française (UDSF). In 2024, JSS held a masterclass at the ASI Boot Camp in Spain to educate young sommeliers on sake. Additionally, JSS participated in international trade fairs, including ProWein, ProWine São Paulo, and Warsaw Wine Experience, to expand distribution channels.
A key milestone in 2024 was sake's inclusion in the service task of the finals at the ASI Contest Best Sommelier of Europe, Africa, and the Middle East 2024, furthering its recognition among sommeliers. Furthermore, the registration of 'Traditional knowledge and skills of sake-making with koji mold in Japan' as a UNESCO Intangible Cultural Heritage in December 2024 has boosted sake's global presence. In 2025, JSS aims to accelerate expansion into Latin America, Eastern Europe, and Southeast Asia to drive further export growth.
Takeshi Itani
SOURCE: Japan Sake and Shochu Makers Association
Copyright Business Wire 2025.
PUB: 02/06/2025 10:00 PM/DISC: 02/06/2025 10:02 PM
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
44 minutes ago
- Associated Press
CORRECTING and REPLACING Berkshire Hathaway Inc. News Release
OMAHA, Neb.--(BUSINESS WIRE)--Aug 2, 2025-- First paragraph under second table, second sentence should read: At June 30, 2025, insurance float (the net liabilities we assume under insurance contracts) was approximately $174 billion, an increase of $3 billion since yearend 2024 (instead of At June 30, 2024, insurance float (the net liabilities we assume under insurance contracts) was approximately $174 billion, an increase of $3 billion since yearend 2024.) The updated release reads: BERKSHIRE HATHAWAY INC. NEWS RELEASE Berkshire Hathaway Inc. (BRK.A; BRK.B) – Berkshire's operating results for the second quarter and first six months of 2025 and 2024 are summarized in the following paragraphs. However, we urge investors and reporters to read our 10-Q, which has been posted at The limited information that follows in this press release is not adequate for making an informed investment judgment. Earnings of Berkshire Hathaway Inc. and its consolidated subsidiaries for the second quarter and first six months of 2025 and 2024 are summarized below. Earnings are stated on an after-tax basis. (Dollar amounts are in millions, except for per share amounts). Generally Accepted Accounting Principles ('GAAP') require that we include the changes in unrealized gains (losses) of our equity security investments as a component of investment gains (losses) in our earnings statements. In the table above, investment gains (losses) in 2025 include gains of $1.5 billion in the second quarter and losses of $5.9 billion in the first six months and in 2024 include losses of $28.2 billion in the second quarter and $37.9 billion in the first six months due to changes during the second quarter and the first six months in the unrealized gains that existed in our equity security investment holdings. Investment gains (losses) in 2025 also include after-tax realized gains of $4.2 billion in the second quarter and $6.6 billion in the first six months and in 2024 include after-tax realized gains on sales of investments of $47.0 billion in the second quarter and $58.2 billion in the first six months. The amount of investment gains (losses) in any given quarter is usually meaningless and delivers figures for net earnings per share that can be extremely misleading to investors who have little or no knowledge of accounting rules. An analysis of Berkshire's operating earnings follows (dollar amounts are in millions). On June 30, 2025, there were 1,438,223 Class A equivalent shares outstanding. At June 30, 2025, insurance float (the net liabilities we assume under insurance contracts) was approximately $174 billion, an increase of $3 billion since yearend 2024. Use of Non-GAAP Financial Measures This press release includes certain non-GAAP financial measures. The reconciliations of such measures to the most comparable GAAP figures in accordance with Regulation G are included herein. Berkshire presents its results in the way it believes will be most meaningful and useful, as well as most transparent, to the investing public and others who use Berkshire's financial information. That presentation includes the use of certain non-GAAP financial measures. In addition to the GAAP presentations of net earnings, Berkshire shows operating earnings defined as net earnings exclusive of investment gains (losses), impairments of goodwill and intangible assets and other-than-temporary impairments of equity method investments. Although the investment of insurance and reinsurance premiums to generate investment income and investment gains or losses is an integral part of Berkshire's operations, the generation of investment gains or losses is independent of the insurance underwriting process. Moreover, as previously described, under applicable GAAP accounting requirements, we are required to include the changes in unrealized gains (losses) of our equity security investments as a component of investment gains (losses) in our periodic earnings statements. In sum, investment gains (losses) for any particular period are not indicative of quarterly business performance. About Berkshire Berkshire Hathaway and its subsidiaries engage in diverse business activities including insurance and reinsurance, utilities and energy, freight rail transportation, manufacturing, retailing and services. Common stock of the company is listed on the New York Stock Exchange, trading symbols BRK.A and BRK.B. Cautionary Statement Certain statements contained in this press release are 'forward looking' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are not guaranties of future performance and actual results may differ materially from those forecasted. View source version on CONTACT: Marc D. Hamburg 402-346-1400 KEYWORD: UNITED STATES NORTH AMERICA NEBRASKA INDUSTRY KEYWORD: RESIDENTIAL BUILDING & REAL ESTATE RETAIL CONSTRUCTION & PROPERTY ENERGY MANUFACTURING INSURANCE FINANCE PROFESSIONAL SERVICES RAIL AIR TRANSPORT OTHER MANUFACTURING OTHER ENERGY FOOD/BEVERAGE UTILITIES FASHION SOURCE: Berkshire Hathaway Inc. Copyright Business Wire 2025. PUB: 08/02/2025 11:48 AM/DISC: 08/02/2025 11:48 AM
Yahoo
14 hours ago
- Yahoo
UnitedHealth Group Announces Changes to Leadership Team
July 31, 2025--(BUSINESS WIRE)--UnitedHealth Group (NYSE: UNH) today announced Wayne S. DeVeydt has been appointed its chief financial officer, effective September 2, 2025. John F. Rex, who joined the company in 2012 and has been CFO since 2016, will become strategic advisor to the CEO on the same date. "Wayne DeVeydt combines deep financial acumen and operating experience with the mission-oriented and compassionate approach to health care that is a perfect fit for UnitedHealth Group," said Stephen J. Hemsley, company chairman and chief executive officer. "John Rex has been an exceptional leader, having helped guide our company through substantial change with both strategic vision and strong commitment to our mission," said Hemsley. "I look forward to his continued insights as UnitedHealth Group moves forward." DeVeydt, 55, most recently has been a managing director and operating partner at Bain Capital, working with client leaders on operational improvement and growth acceleration. From 2018-2020, he was chairman and CEO of Surgery Partners, Inc. in Nashville, expanding the operational scale and financial performance of the surgical services firm. He joined Anthem, Inc. (now Elevance) in 2005 and served as its chief financial officer from 2007 to 2016. Prior to joining Anthem, DeVeydt served as a partner with PricewaterhouseCoopers LLP, with a focus on the health care sector. "There is no organization besides UnitedHealth Group that presents the kinds of opportunities to make a difference in health care, from individual patient care to broad system efficiency, so I am eagerly looking forward to joining the team," said DeVeydt. "I've been fortunate to know John Rex for over two decades and am honored to follow a leader of his caliber." Rex, 63, joined UnitedHealth Group as chief financial officer of the company's then newly established Optum business and previously had spent his career focused in health care across multiple roles and sectors. "This pivotal moment for UnitedHealth Group is the right time for a new yet greatly experienced executive like Wayne DeVeydt, and I look forward to supporting him and the entire leadership team while continuing to advise on a range of matters," said Rex. About UnitedHealth Group UnitedHealth Group is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health benefits, enabling affordable coverage, simplifying the health care experience and delivering access to high-quality care. Visit UnitedHealth Group at and follow UnitedHealth Group on LinkedIn. View source version on Contacts Media: uhgmedia@ UnitedHealth Group Media Sign in to access your portfolio
Miami Herald
17 hours ago
- Miami Herald
Leaked Prelude Pricing: Too Pricey for Its Own Good?
The Honda Prelude is making a comeback. On paper, it has all the right ingredients for a frugal sports coupe: sleek styling, a hybrid powertrain, and a nameplate that still resonates with enthusiasts. But according to a leak from Japanese outlet Creative Trend, it might arrive with a price tag that could alienate the very buyers who made it iconic. According to the leak, Honda will officially debut the new Prelude on September 4, and orders in Japan will open the next day. The first production run will be limited to just 2,000 units. The leaked Japanese MSRP puts the 2026 Prelude at ¥6,179,800, or roughly $41,000. That's significantly more than the Civic Type R, which starts at ¥4,997,300 in Japan. It also puts it uncomfortably close to the price of more performance-focused cars. A limited-run ON Edition will also be offered at launch for ¥6,540,000 (about $43,400), with unique details like a black roof and bundled extras. However, buyers must pay in full, are limited to one unit, and cannot resell it after purchase. For a Honda coupe, that's unusually exclusive. The Prelude shares its platform with the Civic, but Honda is treating it as more than a badge-engineering job. Under the hood is a 2.0-liter hybrid system with two electric motors, paired with a CVT. Brakes and suspension are adapted from the Civic Type R, and the Prelude gets heated seats, a digital dash, and a BOSE sound system. Adaptive dampers and 19-inch wheels come standard, along with Google-based infotainment. It seems like less of a reskinned Civic coupe, and more like a grown-up Type R that you can cruise in without needing a chiropractor. Its ¥6,179,800 ($41,000) price tag feels especially steep when compared to what else the market offers. The Nissan Z starts at ¥5,497,800 ($36,500) in Japan, while the BMW Z4 - imported from Austria - starts at ¥4,995,000 ($33,200). Both are rear-wheel-drive and pack more power. The Prelude, by contrast, is front-wheel-drive only and CVT-exclusive. If built in Japan, export fees could bump the US price even higher. Initially, we thought it would go head-to-head with cheaper, enthusiast-approved options like the Toyota GR86 and Mazda MX-5 Miata. But if not, it's hard to see how this version of the Prelude will connect with the younger buyers it seems to target. Copyright 2025 The Arena Group, Inc. All Rights Reserved.
